Covira Surgical

Covira Surgical is a biotech company that develops medications that work by modulating the biological activity of the gut microbiome. This company is based on the work of Dr. John Alverdy, MD, a world authority on the molecular basis of post-surgical infections. Its platform technology generated a lead asset (CS-0003) that modulates bacterial virulence and restores microbial communities to prevent post-surgical infection.